Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis
The World Journal of Biological Psychiatry · 02.01.2022 · 23 (1) · 78-86
DOI: 10.1080/15622975.2021.1925153 ↗Kurz gefasst
Fachartikel in der Zeitschrift The World Journal of Biological Psychiatry, online erschienen am 10.06.2021. Verfasst von Maximilian Cronemeyer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy III, University Hospital Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Catatonia, Electroconvulsive Therapy, Neuroleptic Malignant Syndrome. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Objectives
Malignant catatonia (MC) is a rare, yet potentially life-threatening neuropsychiatric condition. Evidence on its therapy is weak, treatment recommendations are scarce and predominantly unprecise. The aim of this study was to compare the effectiveness of different MC treatment approaches regarding outcome and severity of MC.
Methods
We conducted systematic searches for MC case reports in biomedical databases and the psychiatric archive of University Hospital Ulm. Treatments were compared considering MC severity and temporal aspects.
Results
A total of 117 cases were included. Treatment had a significant influence on outcome: treatment with both benzodiazepines and electroconvulsive therapy (ECT) entailed the most favourable, purely supportive therapy the least favourable outcome. Earlier application of benzodiazepines was significantly associated with a favourable outcome. A classification of MC severity was developed. Patients with severe MC were significantly more often subject to intensive care treatment and had a 78% higher risk of dying than in moderate MC.
Conclusions
This is the first study to introduce a severity classification for MC, and the largest to compare outcomes of MC treatments with clear distinction from neuroleptic malignant syndrome (NMS). Preferable MC treatment should include early initiation of benzodiazepines and ECT. MC severity could serve as a prognostic instrument.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy III, University Hospital Ulm, Ulm, Germany.
- Department of Child and Adolescent Psychiatry/Psychotherapy, University Hospital Ulm, Ulm, Germany.
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
ORCID-Profile: Maximilian Cronemeyer
Zitieren
APA
Cronemeyer, M., Schönfeldt-Lecuona, C., Gahr, M., Keller, F., & Sartorius, A. (2022). Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis. The World Journal of Biological Psychiatry, 23(1), 78-86. https://doi.org/10.1080/15622975.2021.1925153
Vancouver
Cronemeyer M, Schönfeldt-Lecuona C, Gahr M, Keller F, Sartorius A. Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis. The World Journal of Biological Psychiatry. 2022;23(1):78-86. doi:10.1080/15622975.2021.1925153
BibTeX
@article{Cronemeyer2022,
author = {Cronemeyer, Maximilian and Schönfeldt-Lecuona, Carlos and Gahr, Maximilian and Keller, Ferdinand and Sartorius, Alexander},
title = {Malignant catatonia: Severity, treatment and outcome – a systematic case series analysis},
journal = {The World Journal of Biological Psychiatry},
year = {2022},
volume = {23},
number = {1},
pages = {78--86},
doi = {10.1080/15622975.2021.1925153}
}
EUVIMED